EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Carbapenem-Resistant Serratia marcescens: Genomic Plasticity, Virulence Architecture, and the Expanding Threat of Multidrug Resistance

Theodoros Karampatakis iD, Katerina Tsergouli iD, Payam Behzadi iD

Antibiotics · 01.04.2026 · 15 (4) · 359

DOI: 10.3390/antibiotics15040359 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 01.04.2026. Verfasst von Theodoros Karampatakis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, University Hospital Kerry, V92 NX94 Tralee, Ireland. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 477 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serratia marcescens is a highly adaptable Gammaproteobacterium with broad ecological distribution and growing clinical importance. Advances in whole-genome sequencing (WGS) and pangenome analysis reveal extensive genomic plasticity, driven by mobile genetic elements (MGEs) such as plasmids, transposons, integrons, prophages, and extracellular vesicles, which collectively accelerate virulence and antimicrobial resistance (AMR) evolution. S. marcescens displays a dynamic accessory genome enriched in resistance and virulence determinants, supporting persistence in diverse environments, including hospital water systems. Clinically, S. marcescens is an emerging opportunistic pathogen associated with severe healthcare-associated infections, ICU outbreaks, and multidrug-resistant “superbug” phenotypes. Its resistome includes intrinsic AmpC β-lactamase, broad efflux systems, and chromosomal determinants conferring resistance to β-lactams, polymyxins, and multiple additional drug classes, while acquired ESBLs and carbapenemases urther limit therapeutic options. Integrating genomic, evolutionary, and clinical insights underscores the urgent need for improved surveillance, mechanistic understanding, and targeted interventions against carbapenem-resistant S. marcescens (CRSM).

Schlagwörter

Stichwörter der Autor:innen

Serratia marcescensbacterial drug resistancecarbapenem resistancehorizontal gene transferpangenomevirulence factors

Autor:innen und Institutionen

  • Department of Clinical Microbiology, University Hospital Kerry, V92 NX94 Tralee, Ireland.
  • Department of Microbiology, Shahr-e-Qods Branch, Islamic Azad University, Shahr-e Qods 37541-374, Iran.

ORCID-Profile: Theodoros Karampatakis, Katerina Tsergouli, Payam Behzadi

Zitieren

APA

Karampatakis, T., Tsergouli, K., & Behzadi, P. (2026). Carbapenem-Resistant Serratia marcescens: Genomic Plasticity, Virulence Architecture, and the Expanding Threat of Multidrug Resistance. Antibiotics, 15(4), 359. https://doi.org/10.3390/antibiotics15040359

Vancouver

Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-Resistant Serratia marcescens: Genomic Plasticity, Virulence Architecture, and the Expanding Threat of Multidrug Resistance. Antibiotics. 2026;15(4):359. doi:10.3390/antibiotics15040359

BibTeX
@article{Karampatakis2026,
  author = {Karampatakis, Theodoros and Tsergouli, Katerina and Behzadi, Payam},
  title = {Carbapenem-Resistant Serratia marcescens: Genomic Plasticity, Virulence Architecture, and the Expanding Threat of Multidrug Resistance},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {359},
  doi = {10.3390/antibiotics15040359}
}
Kostenlos starten →